Involvement of the opioid system in the anxiolytic-like effects induced by Δ9-tetrahydrocannabinol

Involvement of the opioid system in the anxiolytic-like effects induced by Δ9-tetrahydrocannabinol
复制标题

DOI:
10.1007/s00213-002-1144-9
复制
发表时间:
2002-08-01
期刊:
影响因子:
3.4
通讯作者:
Maldonado, R
Maldonado, R
中科院分区:
医学3区
文献类型:
--
作者:
Berrendero, F;Maldonado, R

文献摘要

被引文献

相似文献

基本原理:最近的研究表明,大麻素诱导的几种药理作用,包括抗伤害和奖励,涉及内源性阿片系统的参与。目的:本研究旨在探讨不同阿片受体参与Delta(9)-四氢大麻酚(THC)诱导的抗焦虑样反应的可能性。方法:给予低剂量THC(0.3 mg/kg)在光-暗箱中产生明显的抗焦虑样反应,如先前报道的。评价了CB1大麻素受体拮抗剂SR 141716 A(0.5 mg/kg)或μ-阿片受体拮抗剂β-funaltamine(5 mg/kg)、δ-阿片受体拮抗剂纳曲吲哚(2.5 mg/kg)和κ-阿片受体拮抗剂去甲-binaltorphimine(2.5 mg/kg)预处理对THC诱导的抗焦虑样反应的影响。结果如下:SR 141716 A完全阻断了THC诱导的抗焦虑样反应,表明这种作用是由CB 1大麻素受体介导的。β-阿片受体拮抗剂β-funalcidamine和δ-阿片受体拮抗剂纳曲吲哚,但不是κ-阿片受体拮抗剂norbinaltorphimine,废除THC抗焦虑样作用,表明参与的μ-和δ-阿片受体在这种行为反应。结论:这些结果表明,内源性阿片系统参与大麻素对焦虑样行为的调节,并为进一步阐明这两个神经元系统之间的相互作用提供了新的发现。
Rationale: Recent studies have shown that several pharmacological actions induced by cannabinoids, including antinociception and reward, involve the participation of the endogenous opioid system. Objectives: The present study was designed to examine the possible involvement of the different opioid receptors in the anxiolytic-like responses induced by Delta(9)-tetrahydrocannabinol (THC). Methods: The administration of a low dose of THC (0.3 mg/kg) produced clear anxiolytic-like responses in the light-dark box, as previously reported. The effects of the pretreatment with the CB1 cannabinoid receptor antagonist, SR 141716A (0.5 mg/kg), or the mu-opioid receptor antagonist, beta-funaltrexamine (5 mg/kg), the delta-opioid receptor antagonist, naltrindole (2.5 mg/kg) and the kappa-opioid receptor antagonist, nor-binaltorphimine (2.5 mg/kg) were evaluated on anxiolytic-like responses induced by THC. Results: SR 141716A completely blocked the anxiolytic-like response induced by THC, suggesting that this effect is mediated by CB1 cannabinoid receptors. The p-opioid receptor antagonist beta-funaltrexamine and the delta-opioid receptor antagonist naltrindole, but not the kappa-opioid receptor antagonist norbinaltorphimine, abolished THC anxiolytic-like effects, suggesting an involvement of mu- and delta-opioid receptors in this behavioural response. Conclusions: These results demonstrate that the endogenous opioid system is involved in the regulation of anxiety-like behaviour by cannabinoids and provide new findings to clarify further the interaction between these two neuronal systems.